about | Maps & Directions | contact | admissions | faculty | alumni & development | library | Tech Support Center | dean's office | Policies & Procedures

Temple University School of Medicine news Temple University School of Medicine news Temple University School of Medicine news

OFFICE OF news communications

News Archive


January 26, 2012



Temple University Hospital (TUH) has reactivated its heart, lung, and heart/lung transplant programs, effective immediately.


The reactivation follows the Hospital’s receipt of interim approval, from the United Network of Organ Sharing (UNOS), to reactive the programs.


“The reactivation of these transplant programs gives Temple the opportunity once again to bring a full range of sophisticated, lifesaving care to patients with end-stage lung and heart disease – from effective medical therapy to bridge-to-transplant procedures to solid-organ transplantation,” said Larry R. Kaiser, MD, FACS, Senior Executive Vice President for Health Sciences for Temple University, Dean of Temple University School of Medicine, and President & CEO of Temple University Health System.


“With the recent recruitment of Dr. T. Sloane Guy as Chief of Cardiothoracic Surgery and Dr. Yoshiya Toyoda as Director of Heart and Lung Transplantation and Mechanical Circulatory Support, we now have in place the strong leadership that is needed to offer heart and lung transplant services that are second to none,” added Dr. Kaiser.


“We appreciate the work of all members of Temple’s transplant teams for their diligent efforts in making these program reactivations a reality … for helping to bring Temple’s excellent transplant services back to the region … and for giving patients in our community – and well beyond – yet another reason for choosing Temple,” said Dr. Kaiser.


Temple University Hospital offers solid-organ transplantation of hearts, lungs, heart-lung, livers, and kidneys; and also provides bone-marrow transplantation services.